Login

Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q1 FY2020
As of Mar 2, 2020
Q3 FY2019
As of Sep 30, 2019
Current Assets
Cash and cash equivalents
Prepaid expenses and deposits
Intangible assets, net
Goodwill
Prepaid expenses and deposits
Total Assets
Current Liabilities
Accounts payable and accrued liabilities
Due to related parties (Note 3)
Total Liabilities
Common stock Authorized: 75,000,000 shares, $0.001 par value 5,731,000 shares issued and outstanding
Due to related parties (Note 3)
Due to related parties
Due to a related party
Total Liabilities
Stockholder's Funds (Deficit)
Common stock Authorized: 200,000,000 shares of common stock, $0.001 par value 70,681,954 and 40,444,083 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
Preferred stock Authorized: 10,000,000 shares of preferred stock, 2,000,000 shares was extinguished as of September 30, 2023 and outstanding as of December 31, 2022, respectively
Capital reserves
Additional paid-in capital
Share subscriptions receivable
Accumulated deficit
Total Stockholder's Funds
TOTAL LIABILITIES AND STOCKHOLDER'S FUNDS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support